Results 81 to 90 of about 11,060 (223)
5G Cloud‐Enabled Telemedicine for Remote Management of Heart Failure Patients With Implantable Cardioverter‐Defibrillators: A Multicenter Open‐Label Randomized Controlled Trial [PDF]
Postoperative follow‐up for patients with implantable cardioverter‐defibrillators and cardiac resynchronization therapy defibrillators (ICD/CRT‐D) is often delayed in remote areas because of geographic barriers and limited healthcare resources, increasing the risk of adverse outcomes. The “Make Changes” study, was a prospective, multicenter, open‐label
Li P +11 more
europepmc +2 more sources
ICD in cardiac resinhronization therapy
Background: Patients with advanced heart failure bears bad prognosis, despite modern medical treatment year mortality rate spans from 30 up to 70%.
Damijan Vokač
doaj
The study examines 76 patients of the German multicenter study COGIA with suspected BrS in 12 centers in Germany. Thirty‐nine patients met the current ESC diagnostic criteria, 34 of whom met the Shanghai Score criteria. Four major arrhythmic events (ACA, SCD, appropriate ICD shock) occurred in the cohort (5.3%), all in the group of patients fulfilling ...
Lea Lippert +35 more
wiley +1 more source
ABSTRACT Introduction In patients with ischemic cardiomyopathy (ICM), recurrent VF may be treated with catheter ablation by targeting triggering premature ventricular complexes (PVCs) and/or ventricular scar homogenization. Data on optimal ablation strategies in patients with non‐ischemic cardiomyopathy (NICM) remain limited.
Kenji Hashimoto +2 more
wiley +1 more source
This article is prepared on the basis of presentations given at the Annual Scientific Sessions of the European Society of Cardiology 2002 in Berlin, Germany.
Ashish Nabar
doaj
Efficacy and Safety of Heart Failure Treatment According to Frailty Status: A Systematic Review
Background Guideline‐directed treatment is often withheld in frail patients with heart failure (HF) due to concerns about intolerability, yet they may benefit given the higher risk of HF complications.
Charlotte M. Nijskens +4 more
doaj +1 more source
ABSTRACT Background Drug‐refractory ventricular tachycardia (VT) after failed radiofrequency (RF) ablation remains a clinical challenge. Pulsed‐field ablation (PFA) is expanding to ventricular applications, but United States experience with focal pulsed‐field‐only catheters in VT is sparse, and pulsed‐field platforms are not equivalent across ...
Jorge L. Reyes +3 more
wiley +1 more source
ABSTRACT Background Pulsed field ablation (PFA) is an emerging non‐thermal ablation modality with proven safety in atrial arrhythmia ablation. However, data on its performance for ventricular arrhythmias (VA) remain limited. Objective To evaluate the feasibility, safety, and efficacy of PFA for complex VA in a multicenter real‐world US registry ...
Narut Prasitlumkum +22 more
wiley +1 more source
Validation of Cardiorespiratory‐Gated Proton Beam Delivery for Stereotactic Arrhythmia Radioablation
Stereotactic arrhythmia radioablation (STAR) with scanned proton beams was performed in a porcine model targeting the left ventricular free wall (A). Dual gating synchronized proton delivery with both respiratory and cardiac motion was compared to single gating using only respiratory motion (B).
Jagdip Kang +17 more
wiley +1 more source

